KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Short term Debt (2018 - 2020)

Emergent BioSolutions (EBS) has 7 years of Short term Debt data on record, last reported at $22.3 million in Q2 2020.

  • For Q2 2020, Short term Debt rose 120.79% year-over-year to $22.3 million; the TTM value through Jun 2020 reached $22.3 million, up 120.79%, while the annual FY2019 figure was $3.2 million, 42.86% down from the prior year.
  • Short term Debt reached $22.3 million in Q2 2020 per EBS's latest filing, up from $3.2 million in the prior quarter.
  • Across five years, Short term Debt topped out at $62.7 million in Q1 2019 and bottomed at $3.2 million in Q4 2019.
  • Average Short term Debt over 3 years is $19.0 million, with a median of $10.1 million recorded in 2019.
  • Peak YoY movement for Short term Debt: plummeted 42.86% in 2019, then skyrocketed 120.79% in 2020.
  • A 3-year view of Short term Debt shows it stood at $5.6 million in 2018, then tumbled by 42.86% to $3.2 million in 2019, then soared by 596.88% to $22.3 million in 2020.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $22.3 million in Q2 2020, $3.2 million in Q4 2019, and $10.1 million in Q3 2019.